Viktor Ljungström
Research physician at Department of Immunology, Genetics and Pathology; Research programme: Cancer Immunotherapy; Research Group Patrick Micke
- E-mail:
- viktor.ljungstrom@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA
Publications
Recent publications
-
Part of Rheumatology & Autoimmunity, p. 60-62, 2026
- DOI for Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome
- Download full text (pdf) of Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome
-
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms
Part of Leukemia, p. 2076-2086, 2025
- DOI for Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms
- Download full text (pdf) of Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms
-
Part of EBioMedicine, 2024
- DOI for Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib
- Download full text (pdf) of Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib
-
Prognostic genome and transcriptome signatures in colorectal cancers
Part of Nature, p. 137-146, 2024
- DOI for Prognostic genome and transcriptome signatures in colorectal cancers
- Download full text (pdf) of Prognostic genome and transcriptome signatures in colorectal cancers
-
Part of Leukemia, p. 2429-2442, 2024
- DOI for The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia
- Download full text (pdf) of The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia
All publications
Articles in journal
-
Part of Rheumatology & Autoimmunity, p. 60-62, 2026
- DOI for Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome
- Download full text (pdf) of Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome
-
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms
Part of Leukemia, p. 2076-2086, 2025
- DOI for Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms
- Download full text (pdf) of Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms
-
Part of EBioMedicine, 2024
- DOI for Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib
- Download full text (pdf) of Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib
-
Prognostic genome and transcriptome signatures in colorectal cancers
Part of Nature, p. 137-146, 2024
- DOI for Prognostic genome and transcriptome signatures in colorectal cancers
- Download full text (pdf) of Prognostic genome and transcriptome signatures in colorectal cancers
-
Part of Leukemia, p. 2429-2442, 2024
- DOI for The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia
- Download full text (pdf) of The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia
-
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
Part of Blood Advances, p. 2794-2806, 2023
- DOI for BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
- Download full text (pdf) of BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
-
Loss of Y and clonal hematopoiesis in blood: two sides of the same coin?
Part of Leukemia, p. 889-891, 2022
- DOI for Loss of Y and clonal hematopoiesis in blood: two sides of the same coin?
- Download full text (pdf) of Loss of Y and clonal hematopoiesis in blood: two sides of the same coin?
-
Part of Blood, p. 3340-3344, 2022
-
Part of British Journal of Haematology, p. 103-113, 2022
-
Part of Leukemia and Lymphoma, p. 2311-2320, 2022
- DOI for Familial platelet disorder due to germline exonic deletions in RUNX1: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium
- Download full text (pdf) of Familial platelet disorder due to germline exonic deletions in RUNX1: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium
-
Part of HemaSphere, 2022
- DOI for Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting
- Download full text (pdf) of Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting
-
Part of Frontiers in Oncology, 2021
- DOI for Consistent B Cell Receptor Immunoglobulin Features Between Siblings in Familial Chronic Lymphocytic Leukemia
- Download full text (pdf) of Consistent B Cell Receptor Immunoglobulin Features Between Siblings in Familial Chronic Lymphocytic Leukemia
-
Part of Haematologica, p. 682-691, 2021
- DOI for Comparative analysis of targeted next-generation sequencing panels for the detection of gene mutations in chronic lymphocytic leukemia: an ERIC multi-center study
- Download full text (pdf) of Comparative analysis of targeted next-generation sequencing panels for the detection of gene mutations in chronic lymphocytic leukemia: an ERIC multi-center study
-
Prognostic and Predictive Implications of Cytogenetics and Genomics
Part of Hematology/Oncology Clinics of North America, p. 703-713, 2021
- DOI for Prognostic and Predictive Implications of Cytogenetics and Genomics
- Download full text (pdf) of Prognostic and Predictive Implications of Cytogenetics and Genomics
-
Part of Leukemia and Lymphoma, p. 2018-2021, 2021
-
Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer
Part of Scientific Reports, 2020
- DOI for Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer
- Download full text (pdf) of Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer
-
Part of Acta Oncologica, p. 417-426, 2020
- DOI for Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis
- Download full text (pdf) of Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis
-
Targeted sequencing reveals the somatic mutation landscape in a Swedish breast cancer cohort
Part of Scientific Reports, 2020
- DOI for Targeted sequencing reveals the somatic mutation landscape in a Swedish breast cancer cohort
- Download full text (pdf) of Targeted sequencing reveals the somatic mutation landscape in a Swedish breast cancer cohort
-
Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome
Part of American Journal of Hematology, 2020
- DOI for Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome
- Download full text (pdf) of Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome
-
DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy
Part of Clinical Epigenetics, 2019
- DOI for DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy
- Download full text (pdf) of DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy
-
Not so lost in translation: RPS15 mutations in CLL
Part of Blood, p. 2317-2319, 2018
-
Part of Haematologica, p. 865-873, 2018
- DOI for Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations
- Download full text (pdf) of Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations
-
Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer
Part of Cancer Research, p. 1730-1740, 2017
-
Part of Leukemia and Lymphoma, p. 220-221, 2017
-
EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia
Part of Leukemia, p. 1547-1554, 2017
-
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma
Part of Blood, p. 2666-2670, 2016
-
Part of Epigenetics, p. 449-455, 2016
-
Part of Blood, p. 1007-1016, 2016
-
Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
Part of Leukemia, p. 2179-2186, 2016
- DOI for Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
- Download full text (pdf) of Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
-
Transposon Mutagenesis Reveals Fludarabine Resistance Mechanisms in Chronic Lymphocytic Leukemia
Part of Clinical Cancer Research, p. 6217-6227, 2016
-
Part of Haematologica, 2016
-
Molecular Profiling In A Population Based Cohort Of Nordic Myelodysplastic Syndrome Patients
Part of Haematologica, p. 72-72, 2016
-
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing
Part of Clinical Cancer Research, p. 4174-4183, 2015
-
Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
Part of Journal of Experimental Medicine, p. 833-843, 2015
- DOI for Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
- Download full text (pdf) of Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
-
Part of Haematologica, p. 370-376, 2015
-
EGR2 Mutations in Chronic Lymphocytic Leukemia: A New Bad Player
Part of Blood, 2015
-
Part of Blood, 2015
-
Part of Haematologica, p. 10-11, 2015
-
EGR2 mutations in chronic lymphocytic leukemiam - a new bad player?
Part of Leukemia and Lymphoma, p. 83-85, 2015
-
Part of American Journal of Pathology, p. 1600-1609, 2015
-
Part of PLOS ONE, 2015
- DOI for Bioinformatic Challenges in Clinical Diagnostic Application of Targeted Next Generation Sequencing: Experience from Pheochromocytoma
- Download full text (pdf) of Bioinformatic Challenges in Clinical Diagnostic Application of Targeted Next Generation Sequencing: Experience from Pheochromocytoma
-
Part of Journal of Molecular Diagnostics, p. 729-739, 2015
-
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts
Part of Blood, p. 233-241, 2015
-
Genomic Disruption of the Histone Methyltransferase SETD2 in Chronic Lymphocytic Leukemia
Part of Blood, 2015
-
Part of Haematologica, p. 313-314, 2014
-
Part of Blood, 2014
-
Part of Blood, 2014
-
Part of Blood, 2014
-
Part of Läkartidningen, p. 898-898, 2012
-
Clonal evolution patterns in high-risk chronic lymphocytic leukemia treated with ibrutinib